BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30148913)

  • 1. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
    Cartier R L; Parra V J; Puga B; Cardemil D
    Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
    Gosavi T; Diong CP; Lim SH
    J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
    Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
    J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral polyradiculopathy with pediatric acute lymphocytic leukemia.
    Anderson SC; Baquis GD; Jackson A; Monteleone P; Kirkwood JR
    Muscle Nerve; 2002 Jan; 25(1):106-10. PubMed ID: 11754193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
    Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
    Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
    Bassan R; Masciulli A; Intermesoli T; Audisio E; Rossi G; Pogliani EM; Cassibba V; Mattei D; Romani C; Cortelezzi A; Corti C; Scattolin AM; Spinelli O; Tosi M; Parolini M; Marmont F; Borlenghi E; Fumagalli M; Cortelazzo S; Gallamini A; Marfisi RM; Oldani E; Rambaldi A
    Haematologica; 2015 Jun; 100(6):786-93. PubMed ID: 25749825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
    von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
    Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive paresthesia and weakness after intrathecal chemotherapy.
    Marshall R; Gupta ND; Palacios E; Neitzschman HR
    J La State Med Soc; 2008; 160(2):92-4. PubMed ID: 18681351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
    Yegin ZA; Aki S; Sucak G; Yagci M
    Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
    Vainionpää L; Kovala T; Tolonen U; Lanning M
    Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelopathy associated with intrathecal methotrexate.
    Rodrigues PGB; Lima TT; Duarte FB; Nóbrega PR
    Pract Neurol; 2022 Apr; 22(2):141-144. PubMed ID: 34716225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation.
    Dornbos D; Elder JB; Otero JJ; Baiocchi RA; Slone HW; Puduvalli VK; Giglio P
    World Neurosurg; 2019 Aug; 128():381-384. PubMed ID: 31128312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
    Sancho JM; Morgades M; Arranz R; Fernández-Abellán P; Deben G; Alonso N; Blanes M; Rodríguez MJ; Nicolás C; Sánchez E; Fernández de Sevilla A; Conde E; Ribera JM;
    Med Clin (Barc); 2008 Oct; 131(11):401-5. PubMed ID: 18928719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute tumor lysis syndrome following intrathecal methotrexate.
    Benekli M; Güllü IH; Savaş MC; Kadayifçi A; Altundağ MK; Tekuzman G; Firat D
    Leuk Lymphoma; 1996 Jul; 22(3-4):361-3. PubMed ID: 8819088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
    Wang Z; Xu W; Liu L; Ding Z
    Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632
    [No Abstract]   [Full Text] [Related]  

  • 18. MR findings in Balint's syndrome, following intrathecal methotrexate and cytarabine therapy in adult acute lymphoblastic leukemia.
    Höllinger P; Zenhäusern R; Schroth G; Mattle HP
    Eur Neurol; 2001; 46(3):166-7. PubMed ID: 11598342
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor Lysis Syndrome: An Unreported Complication of Intrathecal Ara-C.
    Simangan LR; Kline RM
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):227-9. PubMed ID: 24942026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transverse myelopathy following intrathecal administration of chemotherapy.
    Teh HS; Fadilah SA; Leong CF
    Singapore Med J; 2007 Feb; 48(2):e46-9. PubMed ID: 17304378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.